アクセス数 : ?
ダウンロード数 : ?
ID 112041
タイトル別表記
The development and the perspective of Artificial Pancreas
著者
キーワード
Continuous Glucose Monitoring(CGM)
Artificial pancreas
Insulin pump
Type1diabetes
資料タイプ
学術雑誌論文
抄録
Diabetes is characterized as a chronic hyperglycemic status caused by insulin insufficiency from pancreatic beta cells. The artificial pancreas is consisted of Continuous Glucose Monitoring (CGM) and insulin delivery according to the sensor glucose monitoring values. CGM does not monitor blood glucose concentration, but monitors subcutaneous glucose concentration, which is dispersed from blood vessel. The delay of glucose values of CGM is approximately 5 to 10 minutes compared with blood glucose values. Sensor augmented insulin pump 620G, which combines insulin pump and real time CGM is available from February 2015 in Japan. There are two more functions available from spring of 2017 in the United States, in addition to the 620G pump ; i.e. predictive low glucose suspend function, which suspend insulin delivery when hypoglycemia is predicted, and automated basal insulin increase when sensor glucose is high. The development of insulin infusion algorithm is still on the way, however, automated meal time insulin delivery will be introduced near future.
掲載誌名
四国医学雑誌
ISSN
00373699
cat書誌ID
AN00102041
出版者
徳島医学会
73
5-6
開始ページ
221
終了ページ
226
並び順
221
発行日
2017-12-25
フルテキストファイル
言語
jpn
著者版フラグ
出版社版
部局
先端酵素学研究所